rTMS + Aerobic Exercise for Stroke and Depression
(RESTORATION Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether combining aerobic exercise with repetitive transcranial magnetic stimulation (rTMS) can more effectively treat depression in stroke survivors. Both treatments have been shown to alleviate depression, but researchers aim to determine if their combined use offers greater benefits for stroke patients. The goal is to reduce depression, potentially aiding in stroke recovery. Individuals who experienced a stroke in the last 1-5 years, have ongoing depression, and can walk unaided may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve recovery options for stroke survivors.
Do I have to stop taking my current medications for the trial?
The trial requires that you are not currently on antidepressant medications or have not changed your antidepressant dosage in the last 4 weeks. If you are on other medications, the protocol does not specify whether you need to stop them.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that combining repetitive transcranial magnetic stimulation (rTMS) with aerobic exercise is safe and well-tolerated for people who have had a stroke and experience mild depression. Studies have found that this combination treatment does not cause major side effects.
rTMS alone has been safely used to treat depression, and aerobic exercise is well-known for its mental health benefits. Together, these treatments appear effective in alleviating depression after a stroke without causing significant harm.12345Why are researchers excited about this trial?
Researchers are excited about the combination of repetitive transcranial magnetic stimulation (rTMS) and aerobic exercise for treating stroke and depression because it offers a unique dual approach. Most treatments for these conditions involve medication or traditional physical therapy, but this method combines brain stimulation with physical activity. rTMS uses magnetic fields to stimulate nerve cells in the brain, potentially improving mood and cognitive function. Coupled with aerobic exercise, which is known to boost overall brain health and recovery post-stroke, this treatment could enhance both physical and mental rehabilitation in a synergistic way. This novel approach aims to maximize recovery by tackling both the brain and body simultaneously.
What evidence suggests that this trial's treatments could be effective for post-stroke depression?
Research has shown that repetitive transcranial magnetic stimulation (rTMS) combined with aerobic exercise may help treat depression after a stroke. In this trial, participants will be assigned to different treatment arms: one receiving both rTMS and aerobic exercise, another receiving only rTMS, and a third receiving only aerobic exercise. In one study, many participants experienced a 50% or greater improvement in depression symptoms. rTMS alone has effectively reduced depression and addressed some stroke-related brain issues. Aerobic exercise is also known to alleviate depression, so combining it with rTMS might enhance these benefits. Overall, evidence suggests that this combined approach could effectively reduce depression symptoms in stroke survivors.12678
Are You a Good Fit for This Trial?
This trial is for adults aged 21-70 who have had a stroke within the last 1 to 5 years, can walk unassisted at certain speeds, and are experiencing major depression but not on antidepressants or haven't changed their dosage recently. Exclusions include life-threatening conditions, severe heart issues, visual impairments, history of psychosis or suicide attempts, uncontrolled diabetes, seizures, frequent exercise habits (>2 times per week), and other specific health concerns.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive rTMS, treadmill aerobic exercise, or both for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Combining rTMS & Aerobic Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
Duke University
Collaborator
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator